Unnamed: 0,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0001819,GO:0001819,positive regulation of cytokine production,8/16,475/18800,1.6874547463784201e-09,2.2983133645674e-06,8.02873205645309e-07,CD4/HGF/IL10/MMP12/NOS2/ORM1/TNF/TNFRSF8,8
GO:0032635,GO:0032635,interleukin-6 production,5/16,172/18800,2.43455442177249e-07,9.95956168117127e-05,3.47918840705573e-05,HGF/IL10/NOS2/ORM1/TNF,5
GO:0032715,GO:0032715,negative regulation of interleukin-6 production,4/16,69/18800,2.9249814041619e-07,9.95956168117127e-05,3.47918840705573e-05,HGF/IL10/ORM1/TNF,4
GO:0071222,GO:0071222,cellular response to lipopolysaccharide,5/16,217/18800,7.70556411280262e-07,0.0002098995664327,7.3324525873406e-05,CXCL11/CXCL9/IL10/NOS2/TNF,5
GO:0071216,GO:0071216,cellular response to biotic stimulus,5/16,256/18800,1.73968641593683e-06,0.0002773328554284,9.6881096416775e-05,CXCL11/CXCL9/IL10/NOS2/TNF,5
GO:0019221,GO:0019221,cytokine-mediated signaling pathway,6/16,486/18800,1.85927049034423e-06,0.0002773328554284,9.6881096416775e-05,CD4/CXCL11/CXCL9/IL2RA/MMP12/TNF,6
GO:0002439,GO:0002439,chronic inflammatory response to antigenic stimulus,2/16,3/18800,2.03621773442337e-06,0.0002773328554284,9.6881096416775e-05,IL10/TNF,2
GO:0002874,GO:0002874,regulation of chronic inflammatory response to antigenic stimulus,2/16,3/18800,2.03621773442337e-06,0.0002773328554284,9.6881096416775e-05,IL10/TNF,2
GO:0001889,GO:0001889,liver development,4/16,134/18800,4.20237095386457e-06,0.000520329930833,0.0001817676240331,HGF/IL10/TGFA/TNF,4
GO:0051235,GO:0051235,maintenance of location,5/16,331/18800,6.11309335726124e-06,0.0005953881687703,0.0002079878292636,CD4/CXCL11/CXCL9/IL10/TNF,5
GO:0006509,GO:0006509,membrane protein ectodomain proteolysis,3/16,44/18800,6.55713842258111e-06,0.0005953881687703,0.0002079878292636,IL10/PRTN3/TNF,3
GO:1902107,GO:1902107,positive regulation of leukocyte differentiation,4/16,157/18800,7.87861595039462e-06,0.0006125799196489,0.0002139934490156,CD4/IL10/IL2RA/TNF,4
GO:1903708,GO:1903708,positive regulation of hemopoiesis,4/16,157/18800,7.87861595039462e-06,0.0006125799196489,0.0002139934490156,CD4/IL10/IL2RA/TNF,4
GO:0006953,GO:0006953,acute-phase response,3/16,48/18800,8.54553485560266e-06,0.0006125799196489,0.0002139934490156,IL22/ORM1/TNF,3
GO:0050900,GO:0050900,leukocyte migration,5/16,384/18800,1.25675291951047e-05,0.0008558487381866,0.0002989749050624,CXCL11/CXCL9/IL10/PRTN3/TNF,5
GO:0050731,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,4/16,190/18800,1.67277755059237e-05,0.001035601374503,0.0003617681592668,CD4/HGF/TGFA/TNF,4
GO:0060693,GO:0060693,regulation of branching involved in salivary gland morphogenesis,2/16,8/18800,1.8957569017303e-05,0.0011226177826768,0.0003921657297858,HGF/TNF,2
GO:0032102,GO:0032102,negative regulation of response to external stimulus,5/16,429/18800,2.14496828483739e-05,0.0011685787215794,0.0004082213325248,HGF/IL10/IL2RA/MMP12/TNF,5
GO:0050673,GO:0050673,epithelial cell proliferation,5/16,443/18800,2.50304583986522e-05,0.0012737024734806,0.0004449443681994,HGF/IL10/MMP12/TGFA/TNF,5
GO:0050679,GO:0050679,positive regulation of epithelial cell proliferation,4/16,211/18800,2.52496085051231e-05,0.0012737024734806,0.0004449443681994,IL10/MMP12/TGFA/TNF,4
GO:0002443,GO:0002443,leukocyte mediated immunity,5/16,457/18800,2.90620218016798e-05,0.0014136597747817,0.0004938358591864,GZMB/IL10/NOS2/PTGDS/TNF,5
GO:0006809,GO:0006809,nitric oxide biosynthetic process,3/16,75/18800,3.289816008341e-05,0.0014453965817291,0.0005049225248795,IL10/NOS2/TNF,3
GO:1903201,GO:1903201,regulation of oxidative stress-induced cell death,3/16,77/18800,3.56016758981709e-05,0.0015152963304159,0.0005293407074333,HGF/IL10/TNF,3
GO:0046209,GO:0046209,nitric oxide metabolic process,3/16,81/18800,4.14386051870377e-05,0.0017102842504468,0.0005974561258226,IL10/NOS2/TNF,3
GO:2001057,GO:2001057,reactive nitrogen species metabolic process,3/16,82/18800,4.29898993397337e-05,0.0017221247911975,0.000601592399429,IL10/NOS2/TNF,3
GO:0031348,GO:0031348,negative regulation of defense response,4/16,268/18800,6.42100242511479e-05,0.0022424116161554,0.0007833449652231,HGF/IL10/IL2RA/MMP12,4
GO:0034116,GO:0034116,positive regulation of heterotypic cell-cell adhesion,2/16,15/18800,7.08442211956861e-05,0.0024122457317131,0.0008426733679065,IL10/TNF,2
GO:0036473,GO:0036473,cell death in response to oxidative stress,3/16,98/18800,7.32215642949994e-05,0.0024323846480436,0.0008497085253232,HGF/IL10/TNF,3
GO:1902882,GO:1902882,regulation of response to oxidative stress,3/16,101/18800,8.01032348276889e-05,0.0025372233915188,0.0008863319985829,HGF/IL10/TNF,3
GO:0002544,GO:0002544,chronic inflammatory response,2/16,17/18800,9.16690651069841e-05,0.0026011097224106,0.0009086495050078,IL10/TNF,2
GO:0035729,GO:0035729,cellular response to hepatocyte growth factor stimulus,2/16,17/18800,9.16690651069841e-05,0.0026011097224106,0.0009086495050078,HGF/IL10,2
GO:0031645,GO:0031645,negative regulation of nervous system process,2/16,19/18800,0.0001151459815063,0.0030750750355222,0.0010742205085833,IL10/TNF,2
GO:0035728,GO:0035728,response to hepatocyte growth factor,2/16,19/18800,0.0001151459815063,0.0030750750355222,0.0010742205085833,HGF/IL10,2
GO:0060326,GO:0060326,cell chemotaxis,4/16,315/18800,0.0001200253265858,0.0031437402848057,0.0010982074416355,CXCL11/CXCL9/HGF/IL10,4
GO:0006959,GO:0006959,humoral immune response,4/16,317/18800,0.0001229910340055,0.0031606375153879,0.0011041101761769,CXCL11/CXCL9/PRTN3/TNF,4
GO:0009895,GO:0009895,negative regulation of catabolic process,4/16,324/18800,0.0001337923216221,0.0033131844008976,0.0011573996052289,HGF/IL10/NOS2/TNF,4
GO:0019730,GO:0019730,antimicrobial humoral response,3/16,122/18800,0.0001403732035812,0.0034140768442436,0.00119264451163,CXCL11/CXCL9/PRTN3,3
GO:0051043,GO:0051043,regulation of membrane protein ectodomain proteolysis,2/16,24/18800,0.0001853889296977,0.0037686525708708,0.0013165089744444,IL10/TNF,2
GO:0051384,GO:0051384,response to glucocorticoid,3/16,139/18800,0.0002064134653355,0.0039577518325038,0.0013825672990893,IL10/IL22/TNF,3
GO:0042742,GO:0042742,defense response to bacterium,4/16,364/18800,0.0002092203611896,0.0039577518325038,0.0013825672990893,CD4/IL10/NOS2/TNF,4
GO:0002719,GO:0002719,negative regulation of cytokine production involved in immune response,2/16,27/18800,0.0002354155323105,0.0040836211192427,0.0014265374031205,IL10/TNF,2
GO:0007159,GO:0007159,leukocyte cell-cell adhesion,4/16,381/18800,0.0002491247074078,0.0042088891617456,0.0014702974736139,CD4/IL10/IL2RA/TNF,4
GO:0009410,GO:0009410,response to xenobiotic stimulus,4/16,411/18800,0.0003325614368577,0.0050893109775314,0.0017778565282048,IL10/NOS2/TGFA/TNF,4
GO:0002696,GO:0002696,positive regulation of leukocyte activation,4/16,421/18800,0.0003643722612479,0.0054535716463704,0.0019051042462009,CD4/IL10/IL2RA/TNF,4
GO:0050850,GO:0050850,positive regulation of calcium-mediated signaling,2/16,34/18800,0.0003749574783466,0.0054724864264498,0.0019117117742911,CD4/TNF,2
GO:0002683,GO:0002683,negative regulation of immune system process,4/16,425/18800,0.0003776899589473,0.0054724864264498,0.0019117117742911,IL10/IL2RA/MMP12/TNF,4
GO:0002822,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,3/16,173/18800,0.0003926670896268,0.0055709643340803,0.0019461132073609,CD4/IL10/TNF,3
GO:0010469,GO:0010469,regulation of signaling receptor activity,3/16,173/18800,0.0003926670896268,0.0055709643340803,0.0019461132073609,IL10/TGFA/TNF,3
GO:1903131,GO:1903131,mononuclear cell differentiation,4/16,433/18800,0.0004053716827903,0.0056338391016367,0.0019680773428702,CD4/IL10/IL2RA/PRTN3,4
GO:0061138,GO:0061138,morphogenesis of a branching epithelium,3/16,185/18800,0.0004777350493069,0.0060889312477434,0.0021270553551124,HGF/IL10/TNF,3
GO:0031099,GO:0031099,regeneration,3/16,188/18800,0.0005007050658937,0.0060889312477434,0.0021270553551124,HGF/IL10/TNF,3
GO:0051281,GO:0051281,positive regulation of release of sequestered calcium ion into cytosol,2/16,40/18800,0.0005197813129347,0.0062649747629839,0.0021885528965675,CXCL11/CXCL9,2
GO:0030574,GO:0030574,collagen catabolic process,2/16,42/18800,0.0005731894874167,0.0068481059812416,0.0023922589871869,MMP12/PRTN3,2
GO:0001763,GO:0001763,morphogenesis of a branching structure,3/16,199/18800,0.0005909790407399,0.0069992474216328,0.0024450574500178,HGF/IL10/TNF,3
GO:0045840,GO:0045840,positive regulation of mitotic nuclear division,2/16,44/18800,0.0006291514868535,0.0073468484716326,0.002566485438734,TGFA/TNF,2
GO:0007623,GO:0007623,circadian rhythm,3/16,205/18800,0.0006443380231956,0.0073468484716326,0.002566485438734,NOS2/PTGDS/TNF,3
GO:1902895,GO:1902895,positive regulation of miRNA transcription,2/16,45/18800,0.0006580877485603,0.0073468484716326,0.002566485438734,IL10/TNF,2
GO:1904707,GO:1904707,positive regulation of vascular associated smooth muscle cell proliferation,2/16,46/18800,0.0006876595616878,0.0075908384596441,0.0026517188219794,IL10/TNF,2
GO:0045776,GO:0045776,negative regulation of blood pressure,2/16,47/18800,0.0007178659600721,0.0078218675009456,0.0027324245385481,NOS2/TNF,2
GO:0031641,GO:0031641,regulation of myelination,2/16,48/18800,0.0007487059785597,0.0080294294708537,0.0028049324683715,HGF/TNF,2
GO:0043457,GO:0043457,regulation of cellular respiration,2/16,50/18800,0.0008122830202799,0.0083996299722439,0.0029342551568546,NOS2/TNF,2
GO:0060688,GO:0060688,regulation of morphogenesis of a branching structure,2/16,51/18800,0.0008450181182511,0.0083996299722439,0.0029342551568546,HGF/TNF,2
GO:0045994,GO:0045994,positive regulation of translational initiation by iron,1/16,1/18800,0.0008510638297868,0.0083996299722439,0.0029342551568546,TNF,1
GO:0061048,GO:0061048,negative regulation of branching involved in lung morphogenesis,1/16,1/18800,0.0008510638297868,0.0083996299722439,0.0029342551568546,TNF,1
GO:0140460,GO:0140460,response to Gram-negative bacterium,1/16,1/18800,0.0008510638297868,0.0083996299722439,0.0029342551568546,TNF,1
GO:1901554,GO:1901554,response to paracetamol,1/16,1/18800,0.0008510638297868,0.0083996299722439,0.0029342551568546,TNF,1
GO:0002274,GO:0002274,myeloid leukocyte activation,3/16,232/18800,0.0009225041866609,0.0089746478730874,0.0031351270103064,IL10/PTGDS/TNF,3
GO:0045661,GO:0045661,regulation of myoblast differentiation,2/16,54/18800,0.0009469981901921,0.0090196610842073,0.0031508515418979,CXCL9/TNF,2
GO:0002703,GO:0002703,regulation of leukocyte mediated immunity,3/16,236/18800,0.0009692448273507,0.009100815527737,0.003179201343641,IL10/NOS2/TNF,3
GO:0051785,GO:0051785,positive regulation of nuclear division,2/16,59/18800,0.0011294900839443,0.0101878509558421,0.0035589370368966,TGFA/TNF,2
GO:0051924,GO:0051924,regulation of calcium ion transport,3/16,251/18800,0.0011578845036454,0.0103752545655595,0.0036244030169509,CD4/CXCL11/CXCL9,3
GO:0061614,GO:0061614,miRNA transcription,2/16,60/18800,0.0011678586284048,0.0103962317116821,0.0036317309944201,IL10/TNF,2
GO:0034113,GO:0034113,heterotypic cell-cell adhesion,2/16,61/18800,0.0012068483375505,0.010604693133831,0.0037045531312246,IL10/TNF,2
GO:0045428,GO:0045428,regulation of nitric oxide biosynthetic process,2/16,61/18800,0.0012068483375505,0.010604693133831,0.0037045531312246,IL10/TNF,2
GO:0002712,GO:0002712,regulation of B cell mediated immunity,2/16,62/18800,0.0012464582602864,0.0106772084937747,0.003729885029126,IL10/TNF,2
GO:0002889,GO:0002889,regulation of immunoglobulin mediated immune response,2/16,62/18800,0.0012464582602864,0.0106772084937747,0.003729885029126,IL10/TNF,2
GO:0080164,GO:0080164,regulation of nitric oxide metabolic process,2/16,64/18800,0.0013275349471371,0.0113006412375053,0.0039476697112237,IL10/TNF,2
GO:0014823,GO:0014823,response to activity,2/16,65/18800,0.0013689998140472,0.0114391272805668,0.0039960472453947,IL10/TNF,2
GO:0072577,GO:0072577,endothelial cell apoptotic process,2/16,65/18800,0.0013689998140472,0.0114391272805668,0.0039960472453947,IL10/TNF,2
GO:1905330,GO:1905330,regulation of morphogenesis of an epithelium,2/16,65/18800,0.0013689998140472,0.0114391272805668,0.0039960472453947,HGF/TNF,2
GO:0042130,GO:0042130,negative regulation of T cell proliferation,2/16,68/18800,0.0014970891463871,0.0124331427888978,0.0043432881525479,IL10/IL2RA,2
GO:1904427,GO:1904427,positive regulation of calcium ion transmembrane transport,2/16,71/18800,0.0016307007390057,0.0124813570692474,0.0043601309183861,CXCL11/CXCL9,2
GO:0002037,GO:0002037,negative regulation of L-glutamate import across plasma membrane,1/16,2/18800,0.0017014485831634,0.0124813570692474,0.0043601309183861,TNF,1
GO:0060557,GO:0060557,positive regulation of vitamin D biosynthetic process,1/16,2/18800,0.0017014485831634,0.0124813570692474,0.0043601309183861,TNF,1
GO:0072564,GO:0072564,blood microparticle formation,1/16,2/18800,0.0017014485831634,0.0124813570692474,0.0043601309183861,TNF,1
GO:0120190,GO:0120190,negative regulation of bile acid secretion,1/16,2/18800,0.0017014485831634,0.0124813570692474,0.0043601309183861,TNF,1
GO:1904905,GO:1904905,negative regulation of endothelial cell-matrix adhesion via fibronectin,1/16,2/18800,0.0017014485831634,0.0124813570692474,0.0043601309183861,MMP12,1
GO:1990267,GO:1990267,response to transition metal nanoparticle,1/16,2/18800,0.0017014485831634,0.0124813570692474,0.0043601309183861,TNF,1
GO:1990268,GO:1990268,response to gold nanoparticle,1/16,2/18800,0.0017014485831634,0.0124813570692474,0.0043601309183861,TNF,1
GO:2000332,GO:2000332,regulation of blood microparticle formation,1/16,2/18800,0.0017014485831634,0.0124813570692474,0.0043601309183861,TNF,1
GO:2000334,GO:2000334,positive regulation of blood microparticle formation,1/16,2/18800,0.0017014485831634,0.0124813570692474,0.0043601309183861,TNF,1
GO:2000573,GO:2000573,positive regulation of DNA biosynthetic process,2/16,73/18800,0.001722830491203,0.0124813570692474,0.0043601309183861,HGF/TNF,2
GO:0002534,GO:0002534,cytokine production involved in inflammatory response,2/16,75/18800,0.0018173957565068,0.0128253524371103,0.0044802993288305,NOS2/TNF,2
GO:0070227,GO:0070227,lymphocyte apoptotic process,2/16,75/18800,0.0018173957565068,0.0128253524371103,0.0044802993288305,IL10/IL2RA,2
GO:0043154,GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,2/16,77/18800,0.0019143890333342,0.0133030503234761,0.0046471742377395,HGF/TNF,2
GO:0045445,GO:0045445,myoblast differentiation,2/16,81/18800,0.0021156296940667,0.0141945204104379,0.0049585928012349,CXCL9/TNF,2
GO:0008625,GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,2/16,85/18800,0.0023264927757103,0.0152340536563343,0.0053217344869488,HGF/TNF,2
GO:0010507,GO:0010507,negative regulation of autophagy,2/16,85/18800,0.0023264927757103,0.0152340536563343,0.0053217344869488,HGF/IL10,2
GO:0032945,GO:0032945,negative regulation of mononuclear cell proliferation,2/16,85/18800,0.0023264927757103,0.0152340536563343,0.0053217344869488,IL10/IL2RA,2
GO:1990874,GO:1990874,vascular associated smooth muscle cell proliferation,2/16,87/18800,0.0024355141375215,0.0155119321032402,0.005418806175643,IL10/TNF,2
GO:0045787,GO:0045787,positive regulation of cell cycle,3/16,329/18800,0.0025110753476597,0.0155119321032402,0.005418806175643,IL10/TGFA/TNF,3
GO:0002904,GO:0002904,positive regulation of B cell apoptotic process,1/16,3/18800,0.0025511547658779,0.0155119321032402,0.005418806175643,IL10,1
GO:0010693,GO:0010693,negative regulation of alkaline phosphatase activity,1/16,3/18800,0.0025511547658779,0.0155119321032402,0.005418806175643,TNF,1
GO:0030886,GO:0030886,negative regulation of myeloid dendritic cell activation,1/16,3/18800,0.0025511547658779,0.0155119321032402,0.005418806175643,IL10,1
GO:0060559,GO:0060559,positive regulation of calcidiol 1-monooxygenase activity,1/16,3/18800,0.0025511547658779,0.0155119321032402,0.005418806175643,TNF,1
GO:1900100,GO:1900100,positive regulation of plasma cell differentiation,1/16,3/18800,0.0025511547658779,0.0155119321032402,0.005418806175643,IL10,1
GO:1901647,GO:1901647,positive regulation of synoviocyte proliferation,1/16,3/18800,0.0025511547658779,0.0155119321032402,0.005418806175643,TNF,1
GO:2001272,GO:2001272,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,1/16,3/18800,0.0025511547658779,0.0155119321032402,0.005418806175643,TNF,1
GO:0050863,GO:0050863,regulation of T cell activation,3/16,342/18800,0.0028026310414816,0.016668923486891,0.0058229796862777,CD4/IL10/IL2RA,3
GO:0045765,GO:0045765,regulation of angiogenesis,3/16,345/18800,0.0028727688306862,0.0170117875973679,0.0059427529129069,HGF/IL10/TNF,3
GO:0002532,GO:0002532,production of molecular mediator involved in inflammatory response,2/16,97/18800,0.0030162233300968,0.0171787043061332,0.0060010621735622,NOS2/TNF,2
GO:1990868,GO:1990868,response to chemokine,2/16,97/18800,0.0030162233300968,0.0171787043061332,0.0060010621735622,CXCL11/CXCL9,2
GO:2001237,GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,2/16,97/18800,0.0030162233300968,0.0171787043061332,0.0060010621735622,HGF/TNF,2
GO:0019233,GO:0019233,sensory perception of pain,2/16,99/18800,0.0031394341209845,0.0172800339070743,0.0060364597928723,IL10/TNF,2
GO:0050764,GO:0050764,regulation of phagocytosis,2/16,99/18800,0.0031394341209845,0.0172800339070743,0.0060364597928723,PRTN3/TNF,2
GO:0002367,GO:0002367,cytokine production involved in immune response,2/16,100/18800,0.00320191717862,0.0172800339070743,0.0060364597928723,IL10/TNF,2
GO:0032963,GO:0032963,collagen metabolic process,2/16,101/18800,0.0032649841269795,0.0172800339070743,0.0060364597928723,MMP12/PRTN3,2
GO:1905477,GO:1905477,positive regulation of protein localization to membrane,2/16,103/18800,0.0033928660494471,0.0172800339070743,0.0060364597928723,GZMB/TNF,2
GO:0002941,GO:0002941,synoviocyte proliferation,1/16,4/18800,0.0034001828833303,0.0172800339070743,0.0060364597928723,TNF,1
GO:0034465,GO:0034465,response to carbon monoxide,1/16,4/18800,0.0034001828833303,0.0172800339070743,0.0060364597928723,IL10,1
GO:0046136,GO:0046136,positive regulation of vitamin metabolic process,1/16,4/18800,0.0034001828833303,0.0172800339070743,0.0060364597928723,TNF,1
GO:1900739,GO:1900739,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,1/16,4/18800,0.0034001828833303,0.0172800339070743,0.0060364597928723,GZMB,1
GO:1900740,GO:1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,1/16,4/18800,0.0034001828833303,0.0172800339070743,0.0060364597928723,GZMB,1
GO:1901671,GO:1901671,positive regulation of superoxide dismutase activity,1/16,4/18800,0.0034001828833303,0.0172800339070743,0.0060364597928723,TNF,1
GO:1905242,GO:1905242,"response to 3,3',5-triiodo-L-thyronine",1/16,4/18800,0.0034001828833303,0.0172800339070743,0.0060364597928723,TNF,1
GO:0002460,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,3/16,370/18800,0.0034999243924361,0.0177208067750855,0.0061904356305268,CD4/IL10/TNF,3
GO:0008637,GO:0008637,apoptotic mitochondrial changes,2/16,107/18800,0.0036555965263552,0.0180395741626661,0.0063017911133202,GZMB/HGF,2
GO:0009615,GO:0009615,response to virus,3/16,392/18800,0.0041166209853467,0.0192242609503511,0.0067156395003931,CXCL9/MMP12/TNF,3
GO:0042176,GO:0042176,regulation of protein catabolic process,3/16,395/18800,0.004205538825778,0.0192242609503511,0.0067156395003931,IL10/NOS2/TNF,3
GO:0035509,GO:0035509,negative regulation of myosin-light-chain-phosphatase activity,1/16,5/18800,0.0042485334405695,0.0192242609503511,0.0067156395003931,TNF,1
GO:0060309,GO:0060309,elastin catabolic process,1/16,5/18800,0.0042485334405695,0.0192242609503511,0.0067156395003931,MMP12,1
GO:0060435,GO:0060435,bronchiole development,1/16,5/18800,0.0042485334405695,0.0192242609503511,0.0067156395003931,MMP12,1
GO:0015718,GO:0015718,monocarboxylic acid transport,2/16,117/18800,0.0043527233150036,0.0193107790066284,0.0067458629809073,NOS2/TNF,2
GO:0071346,GO:0071346,cellular response to interferon-gamma,2/16,118/18800,0.0044255776772119,0.0195069151985848,0.0068143795268261,NOS2/TNF,2
GO:0045347,GO:0045347,negative regulation of MHC class II biosynthetic process,1/16,6/18800,0.0050962069422959,0.0209698908018341,0.0073254429572834,IL10,1
GO:0051712,GO:0051712,positive regulation of killing of cells of another organism,1/16,6/18800,0.0050962069422959,0.0209698908018341,0.0073254429572834,NOS2,1
GO:1903347,GO:1903347,negative regulation of bicellular tight junction assembly,1/16,6/18800,0.0050962069422959,0.0209698908018341,0.0073254429572834,TNF,1
GO:2001270,GO:2001270,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,1/16,6/18800,0.0050962069422959,0.0209698908018341,0.0073254429572834,TNF,1
GO:0006816,GO:0006816,calcium ion transport,3/16,424/18800,0.0051262893796888,0.0210301389612537,0.0073464895358889,CD4/CXCL11/CXCL9,3
GO:0042542,GO:0042542,response to hydrogen peroxide,2/16,128/18800,0.0051851933361124,0.0210812935038363,0.00736435942788,HGF/IL10,2
GO:2000027,GO:2000027,regulation of animal organ morphogenesis,2/16,129/18800,0.005264242517788,0.0213389830631766,0.0074543785026322,HGF/TNF,2
GO:0042060,GO:0042060,wound healing,3/16,429/18800,0.0052964362679904,0.0214057750652907,0.0074777110514811,MMP12/TGFA/TNF,3
GO:0001909,GO:0001909,leukocyte mediated cytotoxicity,2/16,131/18800,0.005424013503516,0.0218362177164389,0.0076280782192058,GZMB/NOS2,2
GO:0006979,GO:0006979,response to oxidative stress,3/16,433/18800,0.0054350057311841,0.0218362177164389,0.0076280782192058,HGF/IL10/TNF,3
GO:0045667,GO:0045667,regulation of osteoblast differentiation,2/16,136/18800,0.0058331567336053,0.022674071994612,0.0079207670929473,HGF/TNF,2
GO:0002317,GO:0002317,plasma cell differentiation,1/16,7/18800,0.0059432038928608,0.022674071994612,0.0079207670929473,IL10,1
GO:0031622,GO:0031622,positive regulation of fever generation,1/16,7/18800,0.0059432038928608,0.022674071994612,0.0079207670929473,TNF,1
GO:0060558,GO:0060558,regulation of calcidiol 1-monooxygenase activity,1/16,7/18800,0.0059432038928608,0.022674071994612,0.0079207670929473,TNF,1
GO:0060638,GO:0060638,mesenchymal-epithelial cell signaling,1/16,7/18800,0.0059432038928608,0.022674071994612,0.0079207670929473,HGF,1
GO:0071316,GO:0071316,cellular response to nicotine,1/16,7/18800,0.0059432038928608,0.022674071994612,0.0079207670929473,TNF,1
GO:0090674,GO:0090674,endothelial cell-matrix adhesion via fibronectin,1/16,7/18800,0.0059432038928608,0.022674071994612,0.0079207670929473,MMP12,1
GO:0042552,GO:0042552,myelination,2/16,138/18800,0.0060006818420623,0.0227658180191893,0.0079528168673572,HGF/TNF,2
GO:1903900,GO:1903900,regulation of viral life cycle,2/16,139/18800,0.0060852697015766,0.0229588291788016,0.0080202417411069,CD4/TNF,2
GO:0050796,GO:0050796,regulation of insulin secretion,2/16,147/18800,0.0067816644843251,0.0243350862434648,0.0085010116562687,NOS2/TNF,2
GO:0007253,GO:0007253,cytoplasmic sequestering of NF-kappaB,1/16,8/18800,0.0067895247962677,0.0243350862434648,0.0085010116562687,IL10,1
GO:0045760,GO:0045760,positive regulation of action potential,1/16,8/18800,0.0067895247962677,0.0243350862434648,0.0085010116562687,TNF,1
GO:0051709,GO:0051709,regulation of killing of cells of another organism,1/16,8/18800,0.0067895247962677,0.0243350862434648,0.0085010116562687,NOS2,1
GO:0070669,GO:0070669,response to interleukin-2,1/16,8/18800,0.0067895247962677,0.0243350862434648,0.0085010116562687,IL2RA,1
GO:0070672,GO:0070672,response to interleukin-15,1/16,8/18800,0.0067895247962677,0.0243350862434648,0.0085010116562687,CD4,1
GO:1901668,GO:1901668,regulation of superoxide dismutase activity,1/16,8/18800,0.0067895247962677,0.0243350862434648,0.0085010116562687,TNF,1
GO:0010821,GO:0010821,regulation of mitochondrion organization,2/16,148/18800,0.0068711622464483,0.0244987512556615,0.0085581849969541,GZMB/HGF,2
GO:0033674,GO:0033674,positive regulation of kinase activity,3/16,476/18800,0.007065029810719,0.0249936898758425,0.0087310826368968,CD4/TGFA/TNF,3
GO:0007346,GO:0007346,regulation of mitotic cell cycle,3/16,478/18800,0.0071472072126445,0.0252189021337356,0.0088097563679175,IL10/TGFA/TNF,3
GO:0007189,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,2/16,155/18800,0.0075127515884122,0.025676794451115,0.0089697125681304,CXCL11/CXCL9,2
GO:0006924,GO:0006924,activation-induced cell death of T cells,1/16,9/18800,0.0076351701561685,0.025676794451115,0.0089697125681304,IL2RA,1
GO:0010692,GO:0010692,regulation of alkaline phosphatase activity,1/16,9/18800,0.0076351701561685,0.025676794451115,0.0089697125681304,TNF,1
GO:0019371,GO:0019371,cyclooxygenase pathway,1/16,9/18800,0.0076351701561685,0.025676794451115,0.0089697125681304,PTGDS,1
GO:0031652,GO:0031652,positive regulation of heat generation,1/16,9/18800,0.0076351701561685,0.025676794451115,0.0089697125681304,TNF,1
GO:0051541,GO:0051541,elastin metabolic process,1/16,9/18800,0.0076351701561685,0.025676794451115,0.0089697125681304,MMP12,1
GO:0090324,GO:0090324,negative regulation of oxidative phosphorylation,1/16,9/18800,0.0076351701561685,0.025676794451115,0.0089697125681304,TNF,1
GO:0097011,GO:0097011,cellular response to granulocyte macrophage colony-stimulating factor stimulus,1/16,9/18800,0.0076351701561685,0.025676794451115,0.0089697125681304,CD4,1
GO:0097012,GO:0097012,response to granulocyte macrophage colony-stimulating factor,1/16,9/18800,0.0076351701561685,0.025676794451115,0.0089697125681304,CD4,1
GO:1903034,GO:1903034,regulation of response to wounding,2/16,166/18800,0.0085738302850581,0.0281386912006003,0.0098297305994832,IL10/TNF,2
GO:0001660,GO:0001660,fever generation,1/16,11/18800,0.0093244362583273,0.0291281701464263,0.0101753867425494,TNF,1
GO:0006527,GO:0006527,arginine catabolic process,1/16,11/18800,0.0093244362583273,0.0291281701464263,0.0101753867425494,NOS2,1
GO:0031284,GO:0031284,positive regulation of guanylate cyclase activity,1/16,11/18800,0.0093244362583273,0.0291281701464263,0.0101753867425494,NOS2,1
GO:0034115,GO:0034115,negative regulation of heterotypic cell-cell adhesion,1/16,11/18800,0.0093244362583273,0.0291281701464263,0.0101753867425494,IL10,1
GO:0070587,GO:0070587,regulation of cell-cell adhesion involved in gastrulation,1/16,11/18800,0.0093244362583273,0.0291281701464263,0.0101753867425494,IL10,1
GO:0071803,GO:0071803,positive regulation of podosome assembly,1/16,11/18800,0.0093244362583273,0.0291281701464263,0.0101753867425494,TNF,1
GO:0075294,GO:0075294,positive regulation by symbiont of entry into host,1/16,11/18800,0.0093244362583273,0.0291281701464263,0.0101753867425494,CD4,1
GO:1900222,GO:1900222,negative regulation of amyloid-beta clearance,1/16,11/18800,0.0093244362583273,0.0291281701464263,0.0101753867425494,TNF,1
GO:1901030,GO:1901030,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,1/16,11/18800,0.0093244362583273,0.0291281701464263,0.0101753867425494,GZMB,1
GO:1903799,GO:1903799,negative regulation of production of miRNAs involved in gene silencing by miRNA,1/16,11/18800,0.0093244362583273,0.0291281701464263,0.0101753867425494,TNF,1
GO:0050777,GO:0050777,negative regulation of immune response,2/16,179/18800,0.0099097609580248,0.0303988613171843,0.0106192791679166,IL10/MMP12,2
GO:0010459,GO:0010459,negative regulation of heart rate,1/16,12/18800,0.0101680580061515,0.0304371318777546,0.0106326482794227,TNF,1
GO:0014854,GO:0014854,response to inactivity,1/16,12/18800,0.0101680580061515,0.0304371318777546,0.0106326482794227,IL10,1
GO:0051798,GO:0051798,positive regulation of hair follicle development,1/16,12/18800,0.0101680580061515,0.0304371318777546,0.0106326482794227,TNF,1
GO:0001906,GO:0001906,cell killing,2/16,185/18800,0.0105557977557707,0.031051828387386,0.0108473811199463,GZMB/NOS2,2
GO:0002664,GO:0002664,regulation of T cell tolerance induction,1/16,13/18800,0.0110110062216033,0.0317732849021689,0.0110994085909115,IL2RA,1
GO:0042362,GO:0042362,fat-soluble vitamin biosynthetic process,1/16,13/18800,0.0110110062216033,0.0317732849021689,0.0110994085909115,TNF,1
GO:0045741,GO:0045741,positive regulation of epidermal growth factor-activated receptor activity,1/16,13/18800,0.0110110062216033,0.0317732849021689,0.0110994085909115,TGFA,1
GO:0048012,GO:0048012,hepatocyte growth factor receptor signaling pathway,1/16,13/18800,0.0110110062216033,0.0317732849021689,0.0110994085909115,HGF,1
GO:0060670,GO:0060670,branching involved in labyrinthine layer morphogenesis,1/16,13/18800,0.0110110062216033,0.0317732849021689,0.0110994085909115,IL10,1
GO:0070572,GO:0070572,positive regulation of neuron projection regeneration,1/16,13/18800,0.0110110062216033,0.0317732849021689,0.0110994085909115,HGF,1
GO:1900121,GO:1900121,negative regulation of receptor binding,1/16,13/18800,0.0110110062216033,0.0317732849021689,0.0110994085909115,IL10,1
GO:0050966,GO:0050966,detection of mechanical stimulus involved in sensory perception of pain,1/16,14/18800,0.0118532814065958,0.0332869469603783,0.0116281783956187,TNF,1
GO:0032872,GO:0032872,regulation of stress-activated MAPK cascade,2/16,198/18800,0.012018258631694,0.0336807988814142,0.0117657632694947,HGF/TNF,2
GO:0009612,GO:0009612,response to mechanical stimulus,2/16,201/18800,0.0123677912825322,0.0343774116873651,0.0120091120509228,TNF/TNFRSF8,2
GO:0045187,GO:0045187,"regulation of circadian sleep/wake cycle, sleep",1/16,15/18800,0.0126948840626955,0.0344474783819691,0.0120335885529407,PTGDS,1
GO:0051956,GO:0051956,negative regulation of amino acid transport,1/16,15/18800,0.0126948840626955,0.0344474783819691,0.0120335885529407,TNF,1
GO:0045216,GO:0045216,cell-cell junction organization,2/16,205/18800,0.0128407823780645,0.0347006857121506,0.012122041843954,PRTN3/TNF,2
GO:0043523,GO:0043523,regulation of neuron apoptotic process,2/16,207/18800,0.0130802407374941,0.0352777977910238,0.0123236452597131,IL10/TNF,2
GO:0050807,GO:0050807,regulation of synapse organization,2/16,209/18800,0.0133216656108478,0.0355217333512681,0.0124088596296261,IL10/TNF,2
GO:0045342,GO:0045342,MHC class II biosynthetic process,1/16,16/18800,0.013535814691122,0.0355217333512681,0.0124088596296261,IL10,1
GO:0050803,GO:0050803,regulation of synapse structure or activity,2/16,215/18800,0.0140576743566854,0.0367358583597061,0.0128329917138783,IL10/TNF,2
GO:0016064,GO:0016064,immunoglobulin mediated immune response,2/16,216/18800,0.0141820452072751,0.0367358583597061,0.0128329917138783,IL10/TNF,2
GO:0032310,GO:0032310,prostaglandin secretion,1/16,17/18800,0.0143760737927484,0.0367358583597061,0.0128329917138783,NOS2,1
GO:0045217,GO:0045217,cell-cell junction maintenance,1/16,17/18800,0.0143760737927484,0.0367358583597061,0.0128329917138783,PRTN3,1
GO:0060252,GO:0060252,positive regulation of glial cell proliferation,1/16,17/18800,0.0143760737927484,0.0367358583597061,0.0128329917138783,TNF,1
GO:1901550,GO:1901550,regulation of endothelial cell development,1/16,17/18800,0.0143760737927484,0.0367358583597061,0.0128329917138783,TNF,1
GO:1903140,GO:1903140,regulation of establishment of endothelial barrier,1/16,17/18800,0.0143760737927484,0.0367358583597061,0.0128329917138783,TNF,1
GO:0002377,GO:0002377,immunoglobulin production,2/16,218/18800,0.0144322391237244,0.0368103177650051,0.0128590027280178,IL10/TNF,2
GO:0050870,GO:0050870,positive regulation of T cell activation,2/16,223/18800,0.0150661576457919,0.0378170282196191,0.0132106783795253,CD4/IL2RA,2
GO:0030730,GO:0030730,sequestering of triglyceride,1/16,18/18800,0.0152156618680993,0.0378170282196191,0.0132106783795253,TNF,1
GO:0034138,GO:0034138,toll-like receptor 3 signaling pathway,1/16,18/18800,0.0152156618680993,0.0378170282196191,0.0132106783795253,TNF,1
GO:0060965,GO:0060965,negative regulation of miRNA-mediated gene silencing,1/16,18/18800,0.0152156618680993,0.0378170282196191,0.0132106783795253,TNF,1
GO:0015732,GO:0015732,prostaglandin transport,1/16,19/18800,0.0160545794173543,0.0386867556804147,0.0135145015592762,NOS2,1
GO:0060340,GO:0060340,positive regulation of type I interferon-mediated signaling pathway,1/16,19/18800,0.0160545794173543,0.0386867556804147,0.0135145015592762,MMP12,1
GO:0071800,GO:0071800,podosome assembly,1/16,19/18800,0.0160545794173543,0.0386867556804147,0.0135145015592762,TNF,1
GO:0045333,GO:0045333,cellular respiration,2/16,231/18800,0.016105279347133,0.0386867556804147,0.0135145015592762,NOS2/TNF,2
GO:0006525,GO:0006525,arginine metabolic process,1/16,20/18800,0.0168928269403468,0.0393973121451238,0.0137627212996336,NOS2,1
GO:0035313,GO:0035313,"wound healing, spreading of epidermal cells",1/16,20/18800,0.0168928269403468,0.0393973121451238,0.0137627212996336,MMP12,1
GO:0042359,GO:0042359,vitamin D metabolic process,1/16,20/18800,0.0168928269403468,0.0393973121451238,0.0137627212996336,TNF,1
GO:0060339,GO:0060339,negative regulation of type I interferon-mediated signaling pathway,1/16,20/18800,0.0168928269403468,0.0393973121451238,0.0137627212996336,MMP12,1
GO:1902004,GO:1902004,positive regulation of amyloid-beta formation,1/16,20/18800,0.0168928269403468,0.0393973121451238,0.0137627212996336,TNF,1
GO:0051402,GO:0051402,neuron apoptotic process,2/16,241/18800,0.0174466459624809,0.0405500542677458,0.0141654104096306,IL10/TNF,2
GO:0010888,GO:0010888,negative regulation of lipid storage,1/16,22/18800,0.0185673139051463,0.0416617488283514,0.0145537603141006,TNF,1
GO:0051000,GO:0051000,positive regulation of nitric-oxide synthase activity,1/16,22/18800,0.0185673139051463,0.0416617488283514,0.0145537603141006,TNF,1
GO:0061042,GO:0061042,vascular wound healing,1/16,22/18800,0.0185673139051463,0.0416617488283514,0.0145537603141006,TNF,1
GO:0070269,GO:0070269,pyroptosis,1/16,22/18800,0.0185673139051463,0.0416617488283514,0.0145537603141006,GZMB,1
GO:0010893,GO:0010893,positive regulation of steroid biosynthetic process,1/16,23/18800,0.0194035543448906,0.0428324813901799,0.0149627340508241,TNF,1
GO:1900120,GO:1900120,regulation of receptor binding,1/16,23/18800,0.0194035543448906,0.0428324813901799,0.0149627340508241,IL10,1
GO:0002922,GO:0002922,positive regulation of humoral immune response,1/16,24/18800,0.0202391267542469,0.0440346495835212,0.0153826892431808,TNF,1
GO:0019835,GO:0019835,cytolysis,1/16,24/18800,0.0202391267542469,0.0440346495835212,0.0153826892431808,GZMB,1
GO:0048143,GO:0048143,astrocyte activation,1/16,24/18800,0.0202391267542469,0.0440346495835212,0.0153826892431808,TNF,1
GO:0035821,GO:0035821,modulation of process of another organism,1/16,25/18800,0.0210740316313205,0.044918358500561,0.0156913965857126,NOS2,1
GO:0051450,GO:0051450,myoblast proliferation,1/16,25/18800,0.0210740316313205,0.044918358500561,0.0156913965857126,HGF,1
GO:0062149,GO:0062149,detection of stimulus involved in sensory perception of pain,1/16,25/18800,0.0210740316313205,0.044918358500561,0.0156913965857126,TNF,1
GO:0050995,GO:0050995,negative regulation of lipid catabolic process,1/16,26/18800,0.0219082694738716,0.0461905000362432,0.0161357956692031,TNF,1
GO:0002227,GO:0002227,innate immune response in mucosa,1/16,27/18800,0.0227418407793164,0.0470735366891017,0.0164442681686946,NOS2,1
GO:0009651,GO:0009651,response to salt stress,1/16,27/18800,0.0227418407793164,0.0470735366891017,0.0164442681686946,TNF,1
GO:0030431,GO:0030431,sleep,1/16,28/18800,0.0235747460447259,0.0482114175869619,0.0168417657850736,PTGDS,1
GO:0042634,GO:0042634,regulation of hair cycle,1/16,28/18800,0.0235747460447259,0.0482114175869619,0.0168417657850736,TNF,1
GO:0002366,GO:0002366,leukocyte activation involved in immune response,2/16,285/18800,0.0238900175027536,0.0487829143009752,0.017041407577124,IL10/PTGDS,2
GO:0001666,GO:0001666,response to hypoxia,2/16,286/18800,0.0240463941280744,0.0490287257521517,0.0171272772547898,NOS2/TNF,2
GO:0042886,GO:0042886,amide transport,2/16,287/18800,0.0242032007788162,0.0492746778187558,0.0172131960538509,NOS2/TNF,2
GO:0031349,GO:0031349,positive regulation of defense response,2/16,289/18800,0.0245181011725704,0.0493988961494687,0.0172565894269726,MMP12/TNF,2
GO:0009914,GO:0009914,hormone transport,2/16,290/18800,0.0246761934256352,0.0495707602444176,0.017316626965358,NOS2/TNF,2
GO:0140014,GO:0140014,mitotic nuclear division,2/16,293/18800,0.0251530294870771,0.0499635455261752,0.017453839228558,TGFA/TNF,2
GO:0060251,GO:0060251,regulation of glial cell proliferation,1/16,30/18800,0.0252385604420033,0.0499635455261752,0.017453839228558,TNF,1
GO:1903579,GO:1903579,negative regulation of ATP metabolic process,1/16,30/18800,0.0252385604420033,0.0499635455261752,0.017453839228558,TNF,1
